RE: Well, well, well27 Mar 2022 11:38
Of course one thing is the Q1 results are hardly going to be lower or probably inline with forecasts. More likely to be alot higher I'd say. Covid testing in January has been very strong for other companies and we are making sales now 2 plus years into the pandemic that were expected to be next to nothing.
So worth thinking about those Q1 figures and what DA and JM's buys mean. They would look absolutely incompetent to the outside world if they bought now and Q1 results were below forecast.
Also, the company has stated it has has no comms with Biosynex over their increasing shareholding. These director buys will fuel a rise to 5.60 shortly IMO, forcing Biosynex to grab more quicker.
Think we are in for an explosive few weeks.